reglab/statecodes huggingface dataset:
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124B - PRECURSOR SUBSTANCES › Section 124B.8 - Missing quantity — reporting.

124B.8 Missing quantity — reporting.
A person who is required to report to the board pursuant to this chapter or a person listed as an exception under section 124B.6 shall report to the board either of the following occurrences within seven days of knowledge of the loss or occurrence:
1. Loss or theft of a precursor substance.
2. A difference between the amount of a precursor substance shipped and the amount of a precursor substance received. If applicable, the report shall include the name of the person who transported the precursor substance and the date of shipment.
90 Acts, ch 1251, §17
C91, §204B.8
C93, §124B.8
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124B - PRECURSOR SUBSTANCES › Section 124B.9 - Sale, transfer, furnishing, or receipt for unlawful purpose — penalty.

124B.9 Sale, transfer, furnishing, or receipt for unlawful purpose — penalty.
1. A person who sells, transfers, or otherwise furnishes a precursor substance with knowledge or the intent that the recipient will use the precursor substance to unlawfully manufacture a controlled substance commits a class “C” felony.
2. A person who receives a precursor substance with the intent that the substance be used unlawfully to manufacture a controlled substance commits a class “C” felony.
90 Acts, ch 1251, §18
C91, §204B.9
C93, §124B.9
2004 Acts, ch 1057, §2
Unlawful manufacture of a controlled substance, see §124.401
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124B - PRECURSOR SUBSTANCES › Section 124B.10 - False statement — penalty.

124B.10 False statement — penalty.
A person who knowingly makes a false statement in connection with any report or record required to be made under this chapter commits an aggravated misdemeanor.
90 Acts, ch 1251, §19
C91, §204B.10
C93, §124B.10
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124B - PRECURSOR SUBSTANCES › Section 124B.11 - Permit requirements — penalty.

124B.11 Permit requirements — penalty.
1. A vendor or a recipient who receives a precursor substance from a source outside the state shall obtain a permit for the transaction from the board. However, a permit is not required of a vendor of a drug containing ephedrine, phenylpropanolamine, or pseudoephedrine or of a cosmetic that contains a precursor substance if the drug or cosmetic is lawfully sold, transferred, or furnished either over the counter without a prescription in accordance with chapter 126 or with a prescription pursuant to chapter 155A.
2. An application for a permit shall be filed in writing and signed by the applicant, and shall set forth the name of the applicant, the business in which the applicant is engaged, the business address of the applicant, and a full description of any precursor substance sold, transferred, or otherwise furnished or received.
3. The board may grant a permit on a form adopted by rule. A permit shall be effective for not more than one year from the date of issuance.
4. An applicant shall pay, at the time of filing an application, a permit fee determined by the board.
5. A permit granted under this chapter may be annually renewed on a date to be determined by the board pursuant to rule, upon the filing of a renewal application and the payment of a permit renewal fee.
6. Permit fees charged by the board shall not exceed the costs incurred by the board in administering this chapter.
7. Selling, transferring, or otherwise furnishing, or receiving a precursor substance without a permit obtained pursuant to this section is a serious misdemeanor.
90 Acts, ch 1251, §20
C91, §204B.11
C93, §124B.11
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124B - PRECURSOR SUBSTANCES › Section 124B.12 - Permit — refusal, suspension, or revocation.

124B.12 Permit — refusal, suspension, or revocation.
The board shall refuse, suspend, or revoke a permit upon finding that any of the following conditions exist:
1. The permit was obtained through fraud, misrepresentation, or deceit.
2. The permittee has violated or has permitted any employee of the permittee to violate any of the laws of this state relating to drugs, controlled substances, cosmetics, or nonprescription drugs, or has violated this chapter, a rule adopted pursuant to this chapter, or any other rule of the board.
90 Acts, ch 1251, §21
C91, §204B.12
C93, §124B.12
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES › Section 124C.1 - Definitions.

124C.1 Definitions.
As used in this chapter, unless the context clearly requires otherwise:
1. “Clandestine laboratory site” means a location or operation, including but not limited to buildings or vehicles equipped with glassware, heating devices, and precursors or related reagents and solvents needed to unlawfully prepare or manufacture controlled substances defined in chapter 124.
2. “Cleanup” means actions necessary to contain, collect, control, identify, analyze, disassemble, treat, remove, or otherwise disperse all substances and materials, including but not limited to those found to be hazardous waste as defined in section 455B.411 and controlled substances defined in chapter 124, including contamination caused by those chemicals or substances.
3. “Commissioner” means the commissioner of public safety.
4. “Department” means the department of public safety.
5. “Hazardous substance” means any substance or mixture of substances that presents a danger to the public health or safety and includes, but is not limited to, a substance that is toxic, corrosive, or flammable, and other substances defined in rules adopted pursuant to section 455B.381 and controlled substances as defined in chapter 124.
6. “Person having control over a clandestine laboratory site” means a person who at any time possesses, produces, handles, stores, uses, transports, or disposes of a hazardous substance or controlled substance used or intended for use at a clandestine laboratory site. A person having control over a clandestine laboratory site does not include persons performing duties listed in section 124C.2 at the direction of the commissioner and does not include a person who is the owner of the property or a person holding a security interest in the property in or upon which the clandestine laboratory site is located unless the person knew that a clandestine laboratory existed in or upon the person’s property.
93 Acts, ch 141, §1; 2000 Acts, ch 1148, §1; 2002 Acts, ch 1119, §12, 200, 201; 2003 Acts, ch 44, §35
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES › Section 124C.2 - Powers and duties of the commissioner.

124C.2 Powers and duties of the commissioner.
1. The commissioner or the commissioner’s designee may use funds appropriated or otherwise available to the department for the following purposes:
a. Administrative services for the identification, assessment, and cleanup of clandestine laboratory sites.
b. Payments to other government agencies or private contractors for services consistent with the management and cleanup of a clandestine laboratory site.
c. Emergency response activities involving clandestine laboratory sites, including surveillance, entry, security, cleanup, and disposal.
2. The commissioner may request the assistance of other state, federal, and local agencies as necessary.
3. The commissioner shall proceed, pursuant to this section, to collect all costs incurred in cleanup of a clandestine laboratory site from the person having control over a clandestine laboratory site.
4. The commissioner shall make all reasonable efforts to recover the full amount of moneys expended, through litigation or otherwise. Moneys recovered shall be deposited with the treasurer of state and credited to the department of public safety.
93 Acts, ch 141, §2; 2009 Acts, ch 41, §184
Referred to in §124C.1
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES › Section 124C.3 - Liability to the state.

124C.3 Liability to the state.
A person having control over a clandestine laboratory site shall be strictly liable to the state for all of the following:
1. The reasonable costs incurred by the state as a result of cleanup of the site.
2. The reasonable costs incurred by the state to evacuate people from the area threatened by the clandestine laboratory site.
3. The reasonable damages to the state for the injury to, destruction of, or loss of natural resources resulting from the clandestine laboratory site, including the costs of assessing the injury, destruction, or loss.
93 Acts, ch 141, §3
Referred to in §124C.4
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES › Section 124C.4 - Claim of state.

124C.4 Claim of state.
1. An amount for which a person having control over a clandestine laboratory is liable to the state shall constitute a lien in favor of the state upon all property and rights to property, real and personal, belonging to that person. This lien shall attach at the time the charges set out in section 124C.3 become due and payable and shall continue for ten years from the time the lien attaches unless sooner released or otherwise discharged. The lien may be extended, within ten years from the date the lien attaches, by filing a notice with the appropriate county official of the appropriate county and from the time of filing the lien shall be extended as to the property in that county for ten years, unless sooner released or otherwise discharged, with no limit on the number of extensions.
2. In order to preserve the lien against subsequent mortgagees, purchasers, or judgment creditors for value and without notice of the lien, the commissioner shall file with the recorder of the county in which the property is located a notice of the lien. A laboratory cleanup lien shall be recorded in the index of income tax liens in the county.
3. Each notice of lien shall be endorsed with the day, hour, and minute when the notice was filed for recording and the document reference number, and the notice shall be preserved, indexed, and recorded in the manner provided for recording real estate mortgages. The lien is effective from the time of its indexing. The department shall pay recording fees as provided by section 331.604 for the recording of the lien or for its satisfaction.
4. Upon payment of a charge for which the commissioner has filed a notice of lien with a county, the commissioner shall immediately file with the county a satisfaction of the charge and the satisfaction of the charge shall be indicated on the index.
5. The attorney general, upon the request of the commissioner, shall bring an action at law or in equity, without bond, to enforce payment of any charges or penalties, and in such action the attorney general shall have the assistance of the county attorney of the county in which the action is pending.
6. The remedies available to the state in this chapter shall be cumulative and no action taken by the commissioner or attorney general shall be construed to be an election on the part of the state to pursue any remedy to the exclusion of any other remedy provided by law.
93 Acts, ch 141, §4; 2002 Acts, ch 1113, §2; 2009 Acts, ch 27, §3; 2009 Acts, ch 41, §185
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES › Section 124C.5 - Liability of state employees or persons providing cleanup assistance.

124C.5 Liability of state employees or persons providing cleanup assistance.
The state and its officers or employees are not liable for damages or injury caused by a condition at a clandestine laboratory site or resulting from action or inaction taken by any officers or employees when acting in their official capacity pursuant to this chapter, unless the damage or injury resulted from intentional wrongdoing or gross negligence.
93 Acts, ch 141, §5
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124C - CLEANUP OF CLANDESTINE LABORATORY SITES › Section 124C.6 - Legal remedies.

124C.6 Legal remedies.
This chapter does not deny a person any legal or equitable rights, remedies, or defenses, or affect any legal relationship other than the legal relationship between the state and a person having control over a clandestine laboratory site.
93 Acts, ch 141, §6
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.3 - Health care practitioner certification — duties.

124E.3 Health care practitioner certification — duties.
1. Prior to a patient’s submission of an application for a medical cannabidiol registration card pursuant to section 124E.4, a health care practitioner shall do all of the following:
a. Determine, in the health care practitioner’s medical judgment, whether the patient whom the health care practitioner has examined and treated suffers from a debilitating medical condition that qualifies for the use of medical cannabidiol under this chapter, and if so determined, provide the patient with a written certification of that diagnosis.
b. Provide explanatory information as provided by the department to the patient about the therapeutic use of medical cannabidiol and the possible risks, benefits, and side effects of the proposed treatment.
2. Subsequently, the health care practitioner shall do the following:
a. Determine, on an annual basis, if the patient continues to suffer from a debilitating medical condition and, if so, issue the patient a new certification of that diagnosis.
b. Otherwise comply with all requirements established by the department pursuant to rule.
3. A health care practitioner may provide, but has no duty to provide, a written certification pursuant to this section.
2017 Acts, ch 162, §6, 25
Referred to in §124E.11
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.5 - Medical cannabidiol board — duties.

124E.5 Medical cannabidiol board — duties.
1. a. A medical cannabidiol board is created consisting of eight practitioners representing the fields of neurology, pain management, gastroenterology, oncology, psychiatry, pediatrics, family medicine, and pharmacy, and one representative from law enforcement.
b. The practitioners shall be licensed in this state and nationally board-certified in their area of specialty and knowledgeable about the use of medical cannabidiol.
c. Applicants for membership on the board shall submit a membership application to the department and the governor shall appoint members from the applicant pool.
d. For purposes of this subsection, “representative from law enforcement” means a regularly employed member of a police force of a city or county, including a sheriff, or of the state patrol, in this state, who is responsible for the prevention and detection of crime and the enforcement of the criminal laws of this state.
2. The medical cannabidiol board shall convene at least twice per year.
3. The duties of the medical cannabidiol board shall include but not be limited to the following:
a. Accepting and reviewing petitions to add medical conditions, medical treatments, or debilitating diseases to the list of debilitating medical conditions for which the medical use of cannabidiol would be medically beneficial under this chapter.
b. Making recommendations relating to the removal or addition of debilitating medical conditions to the list of allowable debilitating medical conditions for which the medical use of cannabidiol under this chapter would be medically beneficial.
c. Working with the department regarding the requirements for the licensure of medical cannabidiol manufacturers and medical cannabidiol dispensaries, including licensure procedures.
d. Advising the department regarding the location of medical cannabidiol manufacturers and medical cannabidiol dispensaries throughout the state.
e. Making recommendations relating to the form and quantity of allowable medical uses of cannabidiol.
4. Recommendations made by the medical cannabidiol board pursuant to subsection 3, paragraphs “b” and “e”, shall be made to the board of medicine for consideration, and if approved, shall be adopted by the board of medicine by rule.
5. On or before January 1 of each year, beginning January 1, 2018, the medical cannabidiol board shall submit a report detailing the activities of the board.
6. The general assembly shall have the sole authority to revise the definition of medical cannabidiol for purposes of this chapter.
2017 Acts, ch 162, §8, 25; 2020 Acts, ch 1116, §17
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.6 - Medical cannabidiol manufacturer licensure.

124E.6 Medical cannabidiol manufacturer licensure.
1. a. The department shall issue a request for proposals to select and license by December 1, 2017, up to two medical cannabidiol manufacturers to manufacture and to possess, cultivate, harvest, transport, package, process, or supply medical cannabidiol within this state consistent with the provisions of this chapter. The department shall license new medical cannabidiol manufacturers or relicense the existing medical cannabidiol manufacturers by December 1 of each year.
b. Information submitted during the application process shall be confidential until a medical cannabidiol manufacturer is licensed by the department unless otherwise protected from disclosure under state or federal law.
2. As a condition for licensure, a medical cannabidiol manufacturer must agree to begin supplying medical cannabidiol to medical cannabidiol dispensaries in this state no later than December 1, 2018.
3. The department shall consider the following factors in determining whether to select and license a medical cannabidiol manufacturer:
a. The technical expertise of the medical cannabidiol manufacturer regarding medical cannabidiol.
b. The qualifications of the medical cannabidiol manufacturer’s employees.
c. The long-term financial stability of the medical cannabidiol manufacturer.
d. The ability to provide appropriate security measures on the premises of the medical cannabidiol manufacturer.
e. Whether the medical cannabidiol manufacturer has demonstrated an ability to meet certain medical cannabidiol production needs for medical use regarding the range of recommended dosages for each debilitating medical condition, the range of chemical compositions of any plant of the genus cannabis that will likely be medically beneficial for each of the debilitating medical conditions, and the form of the medical cannabidiol in the manner determined by the department pursuant to rule.
f. The medical cannabidiol manufacturer’s projection of and ongoing assessment of fees on patients with debilitating medical conditions.
4. A medical cannabidiol manufacturer shall contract with a laboratory to perform spot-check testing of the medical cannabidiol produced by the medical cannabidiol manufacturer as provided in section 124E.7. The department shall require that the laboratory report testing results to the medical cannabidiol manufacturer and the department as determined by the department by rule. If a medical cannabidiol manufacturer contracts with a laboratory other than the state hygienic laboratory at the university of Iowa in Iowa City, the department shall approve the laboratory to perform testing pursuant to this chapter.
5. Each entity submitting an application for licensure as a medical cannabidiol manufacturer shall pay a nonrefundable application fee of seven thousand five hundred dollars to the department.
2017 Acts, ch 162, §9, 25; 2020 Acts, ch 1116, §18
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.8 - Medical cannabidiol dispensary licensure.

124E.8 Medical cannabidiol dispensary licensure.
1. a. The department shall issue a request for proposals to select and license by April 1, 2018, up to five medical cannabidiol dispensaries to dispense medical cannabidiol within this state consistent with the provisions of this chapter. The department shall license new medical cannabidiol dispensaries or relicense the existing medical cannabidiol dispensaries by December 1 of each year.
b. Information submitted during the application process shall be confidential until a medical cannabidiol dispensary is licensed by the department unless otherwise protected from disclosure under state or federal law.
2. As a condition for licensure, a medical cannabidiol dispensary must agree to begin supplying medical cannabidiol to patients by December 1, 2018.
3. The department shall consider the following factors in determining whether to select and license a medical cannabidiol dispensary:
a. The technical expertise of the medical cannabidiol dispensary regarding medical cannabidiol.
b. The qualifications of the medical cannabidiol dispensary’s employees.
c. The long-term financial stability of the medical cannabidiol dispensary.
d. The ability to provide appropriate security measures on the premises of the medical cannabidiol dispensary.
e. The medical cannabidiol dispensary’s projection and ongoing assessment of fees for the purchase of medical cannabidiol on patients with debilitating medical conditions.
4. Each entity submitting an application for licensure as a medical cannabidiol dispensary shall pay a nonrefundable application fee of five thousand dollars to the department.
2017 Acts, ch 162, §11, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.10 - Fees.

124E.10 Fees.
All fees collected by the department under this chapter shall be retained by the department for operation of the medical cannabidiol registration card program and the medical cannabidiol manufacturer and medical cannabidiol dispensary licensing programs. The moneys retained by the department shall be considered repayment receipts as defined in section 8.2 and shall be used for any of the department’s duties under this chapter, including but not limited to the addition of full-time equivalent positions for program services and investigations. Notwithstanding section 8.33, moneys retained by the department pursuant to this section shall not revert to the general fund of the state but shall remain available for expenditure only for the purposes specified in this section.
2017 Acts, ch 162, §13, 25; 2018 Acts, ch 1165, §124, 126
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.13 - Medical cannabidiol source.

124E.13 Medical cannabidiol source.
Medical cannabidiol provided exclusively pursuant to a written certification of a health care practitioner, if not legally available in this state or from any other bordering state, shall be obtained from an out-of-state source.
2017 Acts, ch 162, §16, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.14 - Out-of-state medical cannabidiol dispensaries.

124E.14 Out-of-state medical cannabidiol dispensaries.
The department of public health shall utilize a request for proposals process to select and license by December 1, 2017, up to two out-of-state medical cannabidiol dispensaries from a bordering state to sell and dispense medical cannabidiol to a patient or primary caregiver in possession of a valid medical cannabidiol registration card issued under this chapter.
2017 Acts, ch 162, §17, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.15 - Iowa patients and primary caregivers registering in the state of Minnesota.

124E.15 Iowa patients and primary caregivers registering in the state of Minnesota.
A patient or a primary caregiver with a valid medical cannabidiol registration card issued pursuant to this chapter may register in the state of Minnesota as a visiting qualified patient or primary caregiver and may register with one or more medical cannabis manufacturers registered under the laws of Minnesota.
2017 Acts, ch 162, §18, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.16 - Penalties.

124E.16 Penalties.
1. A person who knowingly or intentionally possesses or uses medical cannabidiol in violation of the requirements of this chapter is subject to the penalties provided under chapters 124 and 453B.
2. A medical cannabidiol manufacturer or a medical cannabidiol dispensary shall be assessed a civil penalty of up to one thousand dollars per violation for any violation of this chapter in addition to any other applicable penalties.
2017 Acts, ch 162, §19, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.17 - Use of medical cannabidiol — smoking prohibited.

124E.17 Use of medical cannabidiol — smoking prohibited.
A patient shall not consume medical cannabidiol possessed or used as authorized under this chapter by smoking medical cannabidiol.
2017 Acts, ch 162, §20, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.18 - Reciprocity.

124E.18 Reciprocity.
A valid medical cannabidiol registration card, or its equivalent, issued under the laws of another state that allows an out-of-state patient to possess or use medical cannabidiol in the jurisdiction of issuance shall have the same force and effect as a valid medical cannabidiol registration card issued pursuant to this chapter, except that an out-of-state patient in this state shall not obtain medical cannabidiol from a medical cannabidiol dispensary in this state.
2017 Acts, ch 162, §21, 25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.19 - Background investigations.

124E.19 Background investigations.
1. The division of criminal investigation of the department of public safety shall conduct thorough background investigations for the purposes of licensing medical cannabidiol manufacturers and medical cannabidiol dispensaries under this chapter. The results of any background investigation conducted pursuant to this section shall be presented to the department.
a. An applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license and their owners, investors, and employees shall submit all required information on a form prescribed by the department of public safety.
b. The department shall charge an applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license a fee determined by the department of public safety and adopted by the department by rule to defray the costs associated with background investigations conducted pursuant to the requirements of this section. The fee shall be in addition to any other fees charged by the department. The fee may be retained by the department of public safety and shall be considered repayment receipts as defined in section 8.2.
2. The department shall require an applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license, their owners and investors, and applicants for employment at a medical cannabidiol manufacturer or medical cannabidiol dispensary to submit fingerprints and other required identifying information to the department on a form prescribed by the department of public safety. The department shall submit the fingerprint cards and other identifying information to the division of criminal investigation of the department of public safety for submission to the federal bureau of investigation for the purpose of conducting a national criminal history record check. The department may require employees and contractors involved in carrying out a background investigation to submit fingerprints and other identifying information for the same purpose.
3. The department may enter into a chapter 28E agreement with the department of public safety to meet the requirements of this section.
4. An applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license shall submit information and fees required by this section at the time of application.
5. The results of background investigations conducted pursuant to this section shall not be considered public records under chapter 22.
2018 Acts, ch 1165, §125, 126
Referred to in §124E.7, 124E.9
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.20 - Observational effectiveness study.

124E.20 Observational effectiveness study.
The department may conduct an observational effectiveness study in cooperation with patients and health care practitioners and pursuant to rules of the department in order to study the effectiveness of medical cannabidiol in the treatment of debilitating medical conditions.
2020 Acts, ch 1116, §24
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.21 - Employer regulation of marijuana use.

124E.21 Employer regulation of marijuana use.
1. Nothing in this chapter shall require an employer to permit or accommodate the use, consumption, possession, transfer, display, transportation, distribution, sale, or growing of marijuana in the workplace.
2. Nothing in this chapter shall prohibit an employer from implementing policies restricting the use of marijuana by employees for the purpose of promoting workplace health and safety.
3. Nothing in this chapter shall prohibit an employer from including in a contract with an employee a provision prohibiting the use of marijuana.
4. Nothing in this chapter shall prohibit an employer from establishing and enforcing a zero-tolerance drug policy or a drug-free workplace by use of a drug testing policy in accordance with section 730.5 or any other procedures provided by federal statutes, federal regulations, or orders issued pursuant to federal law.
2020 Acts, ch 1116, §25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.22 - Regulation of marijuana use by government medical assistance programs, private health insurers, and other entities.

124E.22 Regulation of marijuana use by government medical assistance programs, private health insurers, and other entities.
Nothing in this chapter shall require a government medical assistance program, private health insurer, workers’ compensation carrier, or self-insured employer providing workers’ compensation benefits to reimburse a person for costs associated with the medical use of marijuana.
2020 Acts, ch 1116, §26
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.23 - Regulation of marijuana use on property.

124E.23 Regulation of marijuana use on property.
Nothing in this chapter shall require a person that owns, occupies, or controls a property to allow the use, consumption, possession, transfer, display, transportation, distribution, sale, or growing of marijuana on or in that property.
2020 Acts, ch 1116, §27
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.24 - Limitation of liability.

124E.24 Limitation of liability.
Nothing in this chapter shall create any claim, cause of action, sanction, or penalty, for discrimination or under any other theory of liability, under chapter 216 or any other provision of law, based on an act, omission, policy, or contractual provision permissible under this chapter including but not limited to refusing to hire, discharging, disciplining, discriminating, retaliating, or otherwise taking any adverse employment action against a person with respect to hiring, tenure, or any terms, conditions, or privileges of employment.
2020 Acts, ch 1116, §28
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 124E - MEDICAL CANNABIDIOL ACT › Section 124E.25 - Cannabis-derived products — exemption.

124E.25 Cannabis-derived products — exemption.
This chapter shall not apply to any cannabis-derived investigational product or cannabis-derived product approved as a prescription drug medication by the United States food and drug administration.
2020 Acts, ch 1116, §29
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.1 - Declaration of policy.

125.1 Declaration of policy.
It is the policy of this state:
1. That persons with substance-related disorders be afforded the opportunity to receive quality treatment and directed into rehabilitation services which will help them resume a socially acceptable and productive role in society.
2. To encourage substance abuse education and prevention efforts and to insure that such efforts are coordinated to provide a high quality of services without unnecessary duplication.
3. To insure that substance abuse programs are being operated by individuals who are qualified in their field whether through formal education or through employment or personal experience.
[C71, 73, §123B.2; C75, 77, 79, 81, §125.1]
[A portion of subsection 1 was inadvertently omitted in the 1993 Code]
2011 Acts, ch 121, §24, 62
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.3 - Substance abuse program established.

125.3 Substance abuse program established.
The Iowa department of public health shall develop, implement, and administer a comprehensive substance abuse program pursuant to sections 125.1 and 125.2, this section, and sections 125.7, 125.9, 125.10, 125.12 through 125.21, 125.25, 125.32 through 125.34, and 125.37 through 125.43.
[C62, 66, 71, 73, §123A.2; C75, 77, 79, 81, §125.3; 81 Acts, ch 58, §2]
86 Acts, ch 1245, §1123; 2005 Acts, ch 175, §61; 2021 Acts, ch 80, §64
Referred to in §125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.7 - Duties of the board.

125.7 Duties of the board.
The board shall:
1. Approve the comprehensive substance abuse program, developed by the department pursuant to sections 125.1 through 125.3, this section, and sections 125.9, 125.10, 125.12 through 125.21, 125.25, 125.32 through 125.34, and 125.37 through 125.43.
2. Advise the department on policies governing the performance of the department in the discharge of any duties imposed on the department by law.
3. Advise or make recommendations to the governor and the general assembly relative to substance abuse treatment, intervention, education, and prevention programs in this state.
4. Adopt rules for subsections 1 and 6 and review other rules necessary to carry out the provisions of this chapter, subject to review in accordance with chapter 17A.
5. Investigate the work of the department relating to substance abuse, and for this purpose the board shall have access at any time to all books, papers, documents, and records of the department.
6. Consider and approve or disapprove all applications for a license and all cases involving the renewal, denial, suspension, or revocation of a license.
7. Act as the appeal board regarding funding decisions made by the department.
[C71, 73, §123B.3; C75, 77, 79, 81, §125.7]
86 Acts, ch 1245, §1126; 89 Acts, ch 243, §1; 2005 Acts, ch 175, §62; 2021 Acts, ch 80, §65
Referred to in §125.3
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.9 - Powers of director.

125.9 Powers of director.
The director may:
1. Plan, establish and maintain treatment, intervention, education, and prevention programs as necessary or desirable in accordance with the comprehensive substance abuse program.
2. Make contracts necessary or incidental to the performance of the duties and the execution of the powers of the director, including contracts with public and private agencies, organizations and individuals to pay them for services rendered or furnished to persons with substance-related disorders.
3. Solicit and accept for use any gift of money or property made by will or otherwise, and any grant of money, services or property from the federal government, the state, or any political subdivision thereof or any private source, and do all things necessary to cooperate with the federal government or any of its agencies and the department in making an application for any grant.
4. Coordinate the activities of the department and cooperate with substance abuse programs in this and other states, and make contracts and other joint or cooperative arrangements with state, local or private agencies in this and other states for the treatment of persons with substance-related disorders and for the common advancement of substance abuse programs.
5. Require that a written report, in reasonable detail, be submitted to the director at any time by any agency of this state or of any of its political subdivisions in respect to any substance abuse prevention function, or program for the benefit of persons who are or have been involved in substance abuse, which is being conducted by the agency.
6. Submit to the governor a written report of the pertinent facts at any time the director concludes that any agency of this state or of any of its political subdivisions is conducting any substance abuse prevention function, or program for the benefit of persons who are or have been involved in substance abuse in a manner not consistent with or which impairs achievement of the objectives of the state plan to combat substance abuse, and has failed to effect appropriate changes in the function or program.
7. Keep records and engage in research and the gathering of relevant statistics.
8. Employ a deputy director who shall be exempt from the merit system. The director may employ other staff necessary to carry out the duties assigned to the director.
9. Do other acts and things necessary or convenient to execute the authority expressly granted to the director.
[C62, 66, §123A.5, 123A.7, 123A.8; C71, 73, §123A.7, 123A.8, 123B.17; C75, 77, §125.9, 224B.4, 224B.6; C79, 81, §125.9]
86 Acts, ch 1245, §1128; 87 Acts, ch 8, §1; 90 Acts, ch 1085, §3; 2005 Acts, ch 175, §63; 2011 Acts, ch 121, §29, 62
Referred to in §125.3, 125.7
Merit system, see chapter 8A, subchapter IV
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.12 - Comprehensive program for treatment — regional facilities.

125.12 Comprehensive program for treatment — regional facilities.
1. The board shall review the comprehensive substance abuse program implemented by the department for the treatment of persons with substance-related disorders and concerned family members. Subject to the review of the board, the director shall divide the state into appropriate regions for the conduct of the program and establish standards for the development of the program on the regional level. In establishing the regions, consideration shall be given to city and county lines, population concentrations, and existing substance abuse treatment services.
2. The program of the department shall include:
a. Emergency treatment provided by a facility affiliated with or part of the medical service of a general hospital.
b. Inpatient treatment.
c. Residential treatment.
d. Outpatient and follow-up treatment and rehabilitation.
e. Prevention and education.
f. Assessment.
g. Halfway house treatment.
3. The director shall provide for adequate and appropriate treatment for persons with substance-related disorders and concerned family members admitted under sections 125.33 and 125.34, or under section 125.75, 125.81, or 125.91. Treatment shall not be provided at a correctional institution except for inmates. A mental health professional who is employed by a treatment provider under the program may provide treatment to a person with co-occurring substance-related and mental health disorders. Such treatment may also be provided by a person employed by such a treatment provider who is receiving the supervision required to meet the definition of mental health professional but has not completed the supervision component.
4. The director shall maintain, supervise and control all facilities operated by the director pursuant to this chapter.
5. All appropriate public and private resources shall be coordinated with and utilized in the program if possible.
6. The director shall prepare, publish and distribute annually a list of all facilities.
7. The director may contract for the use of a facility if the director, pursuant to section 125.44, considers this to be an effective and economical course to follow.
[C75, 77, 79, 81, §125.12; 82 Acts, ch 1212, §23]
86 Acts, ch 1001, §3; 86 Acts, ch 1245, §1129; 90 Acts, ch 1085, §5; 2005 Acts, ch 175, §65; 2011 Acts, ch 121, §31, 62; 2012 Acts, ch 1120, §63; 2017 Acts, ch 34, §2
Referred to in §125.3, 125.7, 321J.25
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.14 - Licenses — renewal — fees.

125.14 Licenses — renewal — fees.
The board shall consider all cases involving initial issuance, and renewal, denial, suspension, or revocation of a license. The department shall issue a license to an applicant whom the board determines meets the licensing requirements of this chapter. Licenses shall expire no later than three years from the date of issuance and shall be renewed upon timely application made in the same manner as for initial issuance of a license unless notice of nonrenewal is given to the licensee at least thirty days prior to the expiration of the license. The department shall not charge a fee for licensing or renewal of programs contracting with the department for provision of treatment services. A fee may be charged to other licensees.
[C75, 77, §224B.14, 224B.15; C79, 81, §125.14; 81 Acts, ch 58, §8]
89 Acts, ch 243, §3; 2000 Acts, ch 1140, §19; 2002 Acts, ch 1108, §6; 2005 Acts, ch 175, §67
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.15 - Inspections.

125.15 Inspections.
The department may inspect the facilities and review the procedures utilized by any chemical substitutes or antagonists program, residential program, or nonresidential outpatient program that has as a primary purpose the treatment and rehabilitation of persons with substance-related disorders, for the purpose of ensuring compliance with this chapter and the rules adopted pursuant to this chapter. The examination and review may include case record audits and interviews with staff and patients, consistent with the confidentiality safeguards of state and federal law.
[C75, 77, §224B.16; C79, 81, §125.15]
86 Acts, ch 1245, §1130; 2000 Acts, ch 1140, §20; 2011 Acts, ch 121, §34, 62
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.15A - Licensure — emergencies.

125.15A Licensure — emergencies.
1. The department may place an employee or agent to serve as a monitor in a licensed substance abuse treatment program or may petition the court for appointment of a receiver for a program when any of the following conditions exist:
a. The program is operating without a license.
b. The board has suspended, revoked, or refused to renew the existing license of the program.
c. The program is closing or has informed the department that it intends to close and adequate arrangements for the location of clients have not been made at least thirty days before the closing.
d. The department determines that an emergency exists, whether or not it has initiated revocation or nonrenewal procedures, and because of the unwillingness or inability of the licensee to remedy the emergency, the department determines that a monitor or receiver is necessary. As used in this paragraph, “emergency” means a threat to the health, safety, or welfare of a client that the program is unwilling or unable to correct.
2. The monitor shall observe operation of the program, assist the program with advice regarding compliance with state regulations, and report periodically to the department on the operation of the program.
93 Acts, ch 139, §1; 2005 Acts, ch 175, §68
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.16 - Transfer of license or change of location prohibited.

125.16 Transfer of license or change of location prohibited.
A license issued under this chapter may not be transferred, and the location of the physical facilities occupied or utilized by any program licensed under this chapter shall not be changed without the prior written consent of the board.
[C75, 77, §224B.17; C79, 81, §125.16]
2005 Acts, ch 175, §69
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.17 - License suspension or revocation.

125.17 License suspension or revocation.
Violation of any of the requirements or restrictions of this chapter or of any of the rules adopted pursuant to this chapter is cause for suspension, revocation, or refusal to renew a license. The director shall at the earliest time feasible notify a licensee whose license the board is considering suspending or revoking and shall inform the licensee what changes must be made in the licensee’s operation to avoid such action. The licensee shall be given a reasonable time for compliance, as determined by the director, after receiving such notice or a notice that the board does not intend to renew the license. When the licensee believes compliance has been achieved, or if the licensee considers the proposed suspension, revocation, or refusal to renew unjustified, the licensee may submit pertinent information to the board and the board shall expeditiously make a decision in the matter and notify the licensee of the decision.
[C75, 77, §224B.18; C79, 81, §125.17]
2005 Acts, ch 175, §70
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.18 - Hearing before board.

125.18 Hearing before board.
If a licensee under this chapter makes a written request for a hearing within thirty days of suspension, revocation, or refusal to renew a license, a hearing before the board shall be expeditiously arranged by the department of inspections and appeals whose decision is subject to review by the board. The board shall issue a written statement of the board’s findings within thirty days after conclusion of the hearing upholding or reversing the proposed suspension, revocation, or refusal to renew a license. Action involving suspension, revocation, or refusal to renew a license shall not be taken by the board unless a quorum is present at the meeting. A copy of the board’s decision shall be promptly transmitted to the affected licensee who may, if aggrieved by the decision, seek judicial review of the actions of the board in accordance with the terms of chapter 17A.
[C75, 77, §224B.19; C79, 81, §125.18]
86 Acts, ch 1245, §1131; 2005 Acts, ch 175, §71
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.19 - Reissuance or reinstatement.

125.19 Reissuance or reinstatement.
After suspension, revocation, or refusal to renew a license pursuant to this chapter, the affected licensee shall not have the license reissued or reinstated within one year of the effective date of the suspension, revocation, or expiration upon refusal to renew, unless the board orders otherwise. After that time, proof of compliance with the requirements and restrictions of this chapter and the rules adopted pursuant to this chapter must be presented to the board prior to reinstatement or reissuance of a license.
[C75, 77, §224B.20; C79, 81, §125.19]
2005 Acts, ch 175, §72
Referred to in §125.3, 125.7
2023 Iowa Code › Title IV - PUBLIC HEALTH › Chapter 125 - SUBSTANCE-RELATED DISORDERS › Section 125.20 - Rules.

125.20 Rules.
The department shall establish rules pursuant to chapter 17A requiring facilities to use reasonable accounting and reimbursement systems which recognize relevant cost-related factors for substance abuse patients. A facility shall not be licensed nor shall any payment be made under this chapter to a facility which fails to comply with those rules or which does not permit inspection by the department or examination of all records, including financial records, methods of administration, general and special dietary programs, the disbursement of drugs and methods of supply, and any other records the department deems relevant to the establishment of such a system. However, rules issued pursuant to this paragraph shall not apply to any facility referred to in section 125.13, subsection 2 or section 125.43.
[C77, §125.13(8); C79, 81, §125.20]
86 Acts, ch 1245, §1132
Referred to in §125.3, 125.7